New! Sign up for our free email newsletter.
Science News
from research organizations

Yoga as a potential therapy for cardiovascular disease, metabolic syndrome

Date:
December 29, 2014
Source:
SAGE Publications
Summary:
The potential for yoga to have an impact on concrete, physiological outcomes that represent some of the greatest health burdens today has been demonstrated through new research.
Share:
FULL STORY

Cardiovascular disease (CVD) and metabolic syndrome are major public health problems in the USA and worldwide.

There is promising evidence of Yoga, a popular mind-body practice, on improving cardio-metabolic health.

This review helps strengthen the evidence base for yoga as a potentially effective therapy for such conditions. The results support earlier reviews on the positive benefits of yoga for CVD prevention.

The review demonstrates the potential of yoga to have an impact on concrete, physiological outcomes that represent some of the greatest health burdens today.


Story Source:

Materials provided by SAGE Publications. Note: Content may be edited for style and length.


Journal Reference:

  1. P. Chu, R. A. Gotink, G. Y. Yeh, S. J. Goldie, M. M. Hunink. The effectiveness of yoga in modifying risk factors for cardiovascular disease and metabolic syndrome: A systematic review and meta-analysis of randomized controlled trials. European Journal of Preventive Cardiology, 2014; DOI: 10.1177/2047487314562741

Cite This Page:

SAGE Publications. "Yoga as a potential therapy for cardiovascular disease, metabolic syndrome." ScienceDaily. ScienceDaily, 29 December 2014. <www.sciencedaily.com/releases/2014/12/141229141416.htm>.
SAGE Publications. (2014, December 29). Yoga as a potential therapy for cardiovascular disease, metabolic syndrome. ScienceDaily. Retrieved March 18, 2024 from www.sciencedaily.com/releases/2014/12/141229141416.htm
SAGE Publications. "Yoga as a potential therapy for cardiovascular disease, metabolic syndrome." ScienceDaily. www.sciencedaily.com/releases/2014/12/141229141416.htm (accessed March 18, 2024).

Explore More

from ScienceDaily

RELATED STORIES